Power Law company profile

Anacor Pharmaceutical

Biotech & Life Sciences · Palo Alto, United States · Founded 2000 · IPO 2010 Unicorn

Biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform

Valuation

$5.20B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

8 investors on Anacor Pharmaceutical's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Aberdare Ventures

Rho Capital Partners

Rho Ventures

Series B+ 5 investors entered at this stage

Red Abbey Venture Partners

GSK

Schering

Care Capital

Venrock

Global footprint

Where Anacor Pharmaceutical has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States90.9%

🏳️ Mauritania9.1%

2 countries shown

Patent intelligence

$122M patent portfolio · 36 active families

Estimated portfolio value

$122M

2.3% of market cap · 4.3× smaller than top peer ChemoCentryx ($524M)

36 active patent families

Where Anacor Pharmaceutical innovates Small moleculePharmacologyMedicinal chemistryPharmaceutical drugChemical compound

Where Anacor Pharmaceutical concentrates vs peers

Each axis is a top-10 topic across Anacor Pharmaceutical and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Anacor Pharmaceutical

An AI-synthesized read of the highest-engagement posts about Anacor Pharmaceutical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Anacor Pharmaceutical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles